Yahoo Web Search

Search results

    • Q1 2024 Biomx Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 hour ago

      With the recent merger, we've added a second Phase 2 product candidate, BX211 for the treatment of diabetic foot osteomyelitis or DFO, and I'll review our progress shortly ...

    • Q1 2024 Exscientia PLC Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 hour ago

      Before we begin, I'd like to remind you that we may make forward-looking statements on our call. These may include statements about our projected growth, revenue, business models, preclinical ...